Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, Colantonio LD. Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA. 2020;324:1190–200.

Article  PubMed  Google Scholar 

Kario K, Okura A, Hoshide S, Mogi M. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens Res. 2024;47:1099–102.

Article  PubMed  Google Scholar 

Yano Y, Reis JP, Colangelo LA, et al. Association of blood pressure classification in young adults using the 2017 American college of cardiology/American heart association blood pressure guideline with cardiovascular events later in life. JAMA. 2018;320:1774–82.

Article  PubMed  PubMed Central  Google Scholar 

Son JS, Choi S, Kim K, et al. Association of blood pressure classification in Korean young adults according to the 2017 American college of cardiology/American heart association guidelines with subsequent cardiovascular disease events. JAMA. 2018;320:1783–92.

Article  PubMed  PubMed Central  Google Scholar 

A Randomized Trial of Intensive versus Standard Blood-Pressure Control | New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa1511939 . Accessed 19 Jun 2024

Wang J, Shi X, Ma C, Zheng H, Xiao J, Bian H, Ma Z, Gong L. Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2017;35:10–7.

Article  PubMed  CAS  Google Scholar 

Clark D, Nicholls SJ, St John J, Elshazly MB, Ahmed HM, Khraishah H, Nissen SE, Puri R. Visit-to-visit blood pressure variability, coronary atheroma progression, and clinical outcomes. JAMA Cardiol. 2019;4:437–43.

Article  PubMed  PubMed Central  Google Scholar 

Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S, ACTIVE W Investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118:2029–37.

Article  PubMed  CAS  Google Scholar 

Erkens PMG, ten Cate H, Büller HR, Prins MH. Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. PLoS One. 2012;7:e42269.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vestergaard AS, Skjøth F, Larsen TB, Ehlers LH. The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: a systematic review and meta-regression analysis. PLoS One. 2017;12:e0188482.

Article  PubMed  PubMed Central  Google Scholar 

Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis. 2003;15:213–6.

Article  PubMed  CAS  Google Scholar 

Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236–9.

Article  PubMed  CAS  Google Scholar 

Chung S-C, Pujades-Rodriguez M, Duyx B, Denaxas SC, Pasea L, Hingorani A, Timmis A, Williams B, Hemingway H. Time spent at blood pressure target and the risk of death and cardiovascular diseases. PLoS One. 2018;13:e0202359.

Article  PubMed  PubMed Central  Google Scholar 

Doumas M, Tsioufis C, Fletcher R, Amdur R, Faselis C, Papademetriou V. Time in therapeutic range, as a determinant of all-cause mortality in patients with hypertension. J Am Heart Assoc. 2017;6:e007131.

Article  PubMed  PubMed Central  Google Scholar 

Fatani N, Dixon DL, Van Tassell BW, Fanikos J, Buckley LF. Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol. 2021;77:1290–9.

Article  PubMed  PubMed Central  Google Scholar 

Buckley LF, Baker WL, Van Tassell BW, Cohen JB, Alkhezi O, Bress AP, Dixon DL. Systolic blood pressure time in target range and major adverse kidney and cardiovascular events. Hypertension. 2023;80:305–13.

Article  PubMed  CAS  Google Scholar 

Chen K, Wu Z, Shi R, Wang Q, Yuan X, Wu G, Shi G, Li C, Chen T. Longer time in blood pressure target range improves cardiovascular outcomes among patients with type 2 diabetes: a secondary analysis of a randomized clinical trial. Diabetes Res Clin Pract. 2023;198:110600.

Article  PubMed  Google Scholar 

Lin Z, Xiao Z, Chen W, et al. Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly: a Chinese veteran cohort study. Eur J Prev Cardiol. 2023;30:969–77.

Article  PubMed  Google Scholar 

Chen K, Li C, Cornelius V, et al. Prognostic value of time in blood pressure target range among patients with heart failure. JACC Heart Fail. 2022;10:369–79.

Article  PubMed  Google Scholar 

Huang R, Lin Y, Liu M, Xiong Z, Zhang S, Zhong X, Ye X, Huang Y, Zhuang X, Liao X. Time in target range for systolic blood pressure and cardiovascular outcomes in patients with heart failure with preserved ejection fraction. J Am Heart Assoc. 2022;11:e022765.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Jiang C, Li S, et al. Systolic blood pressure time in target range and incident atrial fibrillation in patients with hypertension: insights from the SPRINT trial. Hypertension. 2023;80:2306–14.

Article  PubMed  CAS  Google Scholar 

Mahfoud F, Mancia G, Schmieder RE, et al. Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range. J Am Coll Cardiol. 2022;80:1871–80.

Article  PubMed  CAS  Google Scholar 

Hughes D, Judge C, Murphy R, Loughlin E, Costello M, Whiteley W, Bosch J, O’Donnell MJ, Canavan M. Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis. JAMA. 2020;323:1934–44.

Article  PubMed  Google Scholar 

Peters R, Xu Y, Fitzgerald O, et al. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. Eur Heart J. 2022;43:4980–90.

Article  PubMed  Google Scholar 

Iadecola C, Yaffe K, Biller J, et al. Impact of hypertension on cognitive function: a scientific statement from the American heart association. Hypertension. 2016;68:e67–94.

Article  PubMed  CAS  Google Scholar 

Jiang He, Chuansheng Zhao, Shanshan Zhong, et al. Effectiveness of blood pressure-lowering intervention on risk of total dementia among patients with hypertension: a cluster-randomized effectiveness trial. 2023.

van Dalen JW, Brayne C, Crane PK, et al. Association of systolic blood pressure with dementia risk and the role of age, U-shaped associations, and mortality. JAMA Intern Med. 2022;182:142–52.

Article  PubMed  Google Scholar 

Li S, Jiang C, Wang Y, et al. Systolic blood pressure time in target range and cognitive outcomes: insights from the SPRINT MIND Trial. Hypertension. 2023;80:1628–36.

Article  PubMed  CAS  Google Scholar 

Belani S, Wahood W, Hardigan P, Placzek AN, Ely S. Accuracy of detecting atrial fibrillation: a systematic review and meta-analysis of wrist-worn wearable technology. Cureus. 2021;13:e20362.

PubMed  PubMed Central  Google Scholar 

Mannhart D, Lischer M, Knecht S, et al. Clinical validation of 5 direct-to-consumer wearable smart devices to detect atrial fibrillation: BASEL wearable study. JACC Clin Electrophysiol. 2023;9:232–42.

Article  PubMed  Google Scholar 

Ford C, Xie CX, Low A, Rajakariar K, Koshy AN, Sajeev JK, Roberts L, Pathik B, Teh AW. Comparison of 2 smart watch algorithms for detection of atrial fibrillation and the benefit of clinician interpretation: SMART WARS study. JACC Clin Electrophysiol. 2022;8:782–91.

Article  PubMed  Google Scholar 

Beevers G, Lip GY, O’Brien E. ABC of hypertension: blood pressure measurement. Part II-conventional sphygmomanom